Sort
21,453 grants matching “tuberculosis”
Glutamine metabolism inhibitors for TB and TB-HIV: dual action as host-directed therapies with antibacterial activity
$780,174William Ramses Bishai · Johns Hopkins University · R01 · FY2020 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine
$780,015Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Linking the behavior of individual host cells to their transcriptional signatures
$780,000Lalita Ramakrishnan · University Of Washington · DP1 · FY2010 · OD
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2023 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2022 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2024 · AI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
$779,991Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2021 · AI
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$779,927Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$779,863Courtney C Aldrich · University Of Minnesota · R01 · FY2021 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$779,863Courtney C Aldrich · University Of Minnesota · R01 · FY2023 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$779,863Courtney C Aldrich · University Of Minnesota · R01 · FY2022 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis
$779,863Courtney C Aldrich · University Of Minnesota · R01 · FY2020 · AI
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
$779,547Amariliz Rivera · Rutgers Biomedical And Health Sciences · R01 · FY2023 · AI
Tulane National Primate Research Center
$779,363Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2010 · RR
Biocontainment Research Support Service(s) Core
$779,113Dominique M Missiakas · University Of Chicago · UC7 · FY2025 · AI
Biocontainment Research Support Service(s) Core
$779,113Dominique M Missiakas · University Of Chicago · UC7 · FY2024 · AI
Integrating genomic and spatial approaches for targeted control of HIV-associated tuberculosis epidemics
$779,086Theodore H Cohen · Yale University · R01 · FY2021 · AI
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$778,923Petros C Karakousis · Johns Hopkins University · R01 · FY2024 · AI
Development of Novel Proteins Synthesis Inhibitors for MDR Tuberculosis
$778,890Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TB
$778,882Neel Rajnikant Gandhi · Albert Einstein College Of Medicine · R01 · FY2011 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$778,756Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
Structural Genomics of Persistence Targets from M. tuberculosis
$778,601James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2006 · AI
Genomics of bacterial pathogens: host response, persistence and transmission
$778,440Ashlee Miriam Earl · Broad Institute, Inc. · U19 · FY2014 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$778,383William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2025 · AI
Discovery of Phospopantetheinyl Transferse Inhibitors Against Mycobacterium tuberculosis
$778,372Jeffrey Aube · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI